rheumatoid arthritis

Zydus gets USFDA approval for Indomethacin suppository with CGT designation

Read more

Enzene Biosciences begins commercial supply of its biosimilar of Adalimumab

Read more

AYUSH Ministry to conduct clinical trial in Ayurveda for rheumatoid arthritis

Read more

Gilead, Galapagos amend commercialisation and development pact for Jyseleca (filgotinib)

Read more

Gilead gets approval for Jyseleca (filgotinib) in Japan for rheumatoid arthritis

Read more

Lupin launches Leflunomide Tablets USP

Read more

Cadila Pharma launches Cadalimab (adalimumab biosimilar) for India

Read more

Dr Reddy’s Laboratories launches penicillamine capsules in US

Read more

Lupin and Mylan launch Nepexto, biosimilar etanercept in German market

Read more

US FDA declines approval for Gilead’s rheumatoid arthritis drug, Filgotinib

Read more